You are currently viewing a new version of our website. To view the old version click .

Biomarkers of Autoimmune Chronic Spontaneous Urticaria

This special issue belongs to the section “Molecular Immunology“.

Special Issue Information

Dear Colleagues,

Biomarkers: An unmet need for the assessment of chronic spontaneous urticaria

Chronic spontaneous urticaria (CSU) is a devastating disease during which patients suffer from transient itchy wheals in association with episodes of angioedema, which are present in 40% of cases, or angioedema alone, in around 10% of cases. CSU is frequently a long-lasting disorder and is associated with co-morbidities such as fatigue, sleeplessness and anxiety, leading to an insufficient quality of life. Auto-reactive T cells and autoimmunity in general are primary factors in the pathogenesis of CSU. The response to treatment (both standard and omalizumab) is unpredictable in most cases, and the ability to predict this is important. Finally, patients frequently ask questions concerning how long the suffering will last, and whether it will come back at some stage once it has gone. The above questions require the usage of possible biomarkers aiming to predict one or more of the above raised issues. In this Special Issue, we aim to focus on biomarkers in the serum and skin of patients with CSU in an attempt to better define the pathogenesis, prognosis and response to treatment.

Prof. Dr. Elias Toubi
Prof. Dr. Zahava Vadasz
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Chronic Spontaneous Urticaria (CSU)
  • autoimmunity
  • cytokines
  • biomarkers
  • chemokines

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Int. J. Mol. Sci. - ISSN 1422-0067